We are live on
!
Find out more
Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$44.4B
1-Year Est. Return
36.05%
This Fund
S&P 500
This Quarter
Est. Return
+0.29%
1 Year Est. Return
+36.05%
3 Year Est. Return
+84.6%
5 Year Est. Return
+116.4%
10 Year Est. Return
+513.43%
AUM
$16.3B
AUM Growth
-$605M
(-3.6%)
Cap. Flow
-$340M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
31.59%
Holding
665
New
90
Increased
197
Reduced
206
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$135M |
| 2 |
Merck
MRK
|
+$129M |
| 3 |
US Bancorp
USB
|
+$91.3M |
| 4 |
Johnson & Johnson
JNJ
|
+$84.2M |
| 5 |
Elevance Health
ELV
|
+$72.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$185M |
| 2 |
AABA
Altaba Inc
AABA
|
+$138M |
| 3 |
Alibaba
BABA
|
+$112M |
| 4 |
TWX
Time Warner Inc
TWX
|
+$87.5M |
| 5 |
Humana
HUM
|
+$87.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.14% |
| 2 | Healthcare | 18.78% |
| 3 | Financials | 10.99% |
| 4 | Communication Services | 9.34% |
| 5 | Consumer Discretionary | 8.28% |
Similar funds
GAM
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2018 Portfolio in Review
As of Q1 2018, Grantham, Mayo, Van Otterloo & Co (GMO) held 665 positions worth $16.3B, down 3.6% from $17B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2018 filing shows 90 new, 197 increased, 206 reduced and 98 closed positions. Its largest new stake was Meta Platforms (Facebook): 752,487 shares worth $120M. The largest sale was Microsoft, an estimated $185M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2018 buy was Meta Platforms (Facebook): 752,487 shares worth $120M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Merck in Q1 2018, an estimated $129M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2018 reduction was Microsoft, cutting an estimated $185M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited CVS Health in Q1 2018, selling an estimated $75.9M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 32% of its $16.3B portfolio in Q1 2018.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 90 new positions and closed 98 in Q1 2018.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 3.6% quarter-over-quarter to $16.3B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2018, filed 15 May 2018.